What YouLabs does

YouLabs is a Singapore-incorporated longevity data company (YouLabs Pte Ltd) with primary operations in Hyderabad, India, focused on shifting healthcare from reactive annual snapshots to longitudinal, biology-driven prevention for the Indian population. The company's core thesis is that Western-derived genomic panels, biomarker reference ranges, and longevity protocols systematically underrepresent South Asian pharmacogenomic variants (SLCO1B1, CYP2C19, CYP2D6, APOE) and Indian clinical baselines, and that a hyper-personalised, trajectory-based protocol stack — refined every 90 days from the member's own genome and biomarkers — is required to address this gap.

The platform is organised into three product lines underpinned by a research division (YouLabs Labs). The consumer flagship, 150, is a physician-managed longevity programme launching in 2027 in Hyderabad, limited to 50 founding-member spots; it combines a 300-biomarker baseline panel (including TruAge and DunedinPACE epigenetic clocks, ApoB, DEXA, VO₂ Max, and continuous glucose monitoring), quarterly in-person physician reviews, an AI WhatsApp monitoring agent for daily check-ins, and personalised phase-based protocol stacks (hepatic correction, metabolic optimisation, peptide support) gated by biomarker clearance. Axis, launching in 2026, is a B2B precision health intelligence platform licensed to corporate health programmes, insurance underwriters, and clinical networks for longevity scoring, protocol intelligence, and biomarker analytics. Dispensary, in development, is a curated marketplace for clinically-validated longevity compounds with members-first access via 150.

YouLabs generates revenue through three mechanisms: subscription concierge fees from the 150 membership (multi-year contracts, pricing not publicly disclosed), licensing of the Axis platform to organisations, and transactional sales through Dispensary. Distribution is hybrid — direct-to-consumer application-only intake for 150, direct enterprise sales for Axis, and an owned e-commerce storefront for Dispensary — all currently scoped to a single domestic market (India, starting in Hyderabad). A $2.6M seed round closed in June 2026 led by Crane Venture Partners with strategic participation from Dr. Reddy's Laboratories and Matrix Pharmacorp.

Name

YouLabs

Legal name

YouLabs Pte Ltd

Website

https://youlabs.co

Company type

Private

Founded year

2026

Operating status

Operating

Headcount range

1–10 employees

Short description

YouLabs is a Singapore-incorporated longevity data company building India-specific genomic, biomarker, and epigenetic reference science to power the 150 physician-managed consumer programme and the Axis B2B precision health intelligence platform, with operations based in Hyderabad.

Ownership category

akta.pro rank

Product category

Precision Longevity Healthcare

NAICS

Direct Life, Health, and Medical Insurance Carriers (52411), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Services for the Elderly and Persons with Disabilities (624120)

SIC

Hospital & Medical Service Plans (6324), Services-Computer Programming, Data Processing, Etc. (7370), Life Insurance (6311)

akta.pro primary industry

Medical Wellness & Longevity (Health Screening, Biohacking, Anti-aging Programs) (THAJAHAI)

akta.pro secondary industries

Healthcare & Wellness Personalization (HDAAAGAI), Chronic Condition Management & Remote Monitoring (e.g., diabetes, HTN) (HLALADAD), Employer/Member Engagement Platforms for Provider-Sponsored Plans (HLACAEAM), Healthy Aging & Cognitive Support Supplements (CRADAGAM), Longevity Reinsurance (FSAOAAAB)

Keywords

• Longevity medicine
• Biomarker tracking
• Physician concierge
• Precision health intelligence
• Epigenetic age analysis

Headquarters

HQ city

Singapore

HQ country

Singapore

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. 150 Membership Programme: Private longevity concierge subscription covering comprehensive biomarker panels, personalised protocols, AI monitoring, quarterly physician reviews, and annual biological record documentation. Operates as a concierge membership model with limited founding member spots.
2. Dispensary Marketplace: Curated marketplace of clinically-validated longevity compounds with evidence documentation, source traceability, and biomarker-matched indications. Revenue from compound sales to members.
3. Axis B2B Platform Licensing: Precision health intelligence platform (longevity score, protocol intelligence, biomarker analytics) licensed to corporate health programmes, insurance underwriters, and clinical networks. Licensing revenue from organisations seeking India-specific prescribing intelligence.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels2 records

Core offering

YouLabs operates an AI-powered longevity platform anchored by three offerings: 150, a physician-managed private longevity concierge membership with 300-biomarker baseline panels, 90-day protocol refinement cycles, and AI WhatsApp monitoring; Axis, a B2B precision health intelligence platform licensing India-specific longevity scores and biomarker analytics to corporate health programmes, insurers, and clinical networks (launching 2026); and Dispensary, a curated marketplace of clinically-validated longevity compounds with members-first access.

Product overview

YouLabs is a longevity data company offering a portfolio of three interconnected products: 150 (consumer flagship - physician-managed AI longevity concierge with quarterly biomarker tracking and personalized protocols), Axis (B2B precision health intelligence platform for organisations launching 2026), and Dispensary (curated marketplace of validated longevity compounds). The research division YouLabs Labs underpins all products with Indian-specific genomic, biomarker, and epigenetic science. The architecture combines AI-driven personalization with physician oversight and longitudinal biomarker data collection.

Differentiator

Problem solved

Functional benefit

Brands

• 150: India's first physician-managed longevity programme - a consumer flagship offering personalised phase-based health protocols with longitudinal biomarker tracking every 90 days.
• Axis
• Dispensary
• YouLabs Labs

Products and services

• 150 Private, physician-managed AI longevity concierge membership for high-net-worth individuals. Combines a 300-biomarker baseline panel with epigenetic age clocks, hyper-personalised phase-based protocols (hepatic correction, metabolic optimisation, peptide support), daily AI WhatsApp check-ins, quarterly in-person physician reviews, and protocols refined every 90 days. Limited to 50 founding members in Hyderabad (2027) by application only with personal physician review of each application.
• Axis B2B precision health intelligence platform that licenses India-specific longevity scores, protocol intelligence, and biomarker analytics to corporate health programmes, insurance underwriters, and clinical networks. Enables organisations to access the same India-calibrated reference data and protocol logic that powers the 150 consumer programme for use in employee wellness, risk stratification, and clinical decision support. Launching 2026.
• Dispensary Curated marketplace of clinically-validated longevity compounds sold with documented evidence base, traceable sourcing, and biomarker-profile-matched indications. Each listing requires evidence documentation and source traceability, with members of the 150 programme receiving first access before broader-market availability.

Quantifiable outcome

• 4x biomarker panels per year vs 1x under conventional medicine
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

AI capability6 records

Feature5 records

Scale indicators6 records

Recent moves9 records

Expansion highlights5 records

Direct peers

• Function Health: US-based membership longevity platform offering 100+ biomarker panels plus personalised insights; most directly comparable in concierge model, biomarker depth, and D2C premium positioning to YouLabs' 150 programme.
• Elysium Health: Science-driven longevity company developing NAD+ supplements (Basis) and other interventions backed by clinical research; comparable in evidence-first longevity positioning and supplement pipeline.
• InsideTracker: Personalised biomarker analysis platform that generates healthspan and longevity recommendations from blood data; comparable in translating biomarker panels into individualised protocols, though US-centric in reference ranges.
• Fountain Life: Operates preventive health and longevity centres with advanced diagnostics (whole-body MRI, biomarker panels) and physician-managed programmes; comparable in concierge preventive medicine model and premium positioning.

Broad incumbents

• Practo: India's leading doctor discovery and telemedicine platform with large clinician network and consumer reach; comparable in Indian health infrastructure footprint and a likely Axis enterprise partner for clinical networks.
• Thorne HealthTech: Established supplements and health analytics company with peer-reviewed formulations and practitioner channel; comparable in evidence-validated longevity products and potential overlap with YouLabs' Dispensary marketplace.
• Apollo Hospitals: India's largest hospital chain with extensive diagnostics, preventive health checks (Apollo ProHealth), and pan-India clinical network; comparable in Indian preventive health offerings and a natural Axis channel for clinical networks and hospitals.
• Tata 1mg: Large Indian digital health platform offering diagnostics, pharmacy, and teleconsultations; comparable in serving Indian consumers with diagnostic testing and health services, and a potential enterprise customer or competitor for Axis.

Regional players

• HealthifyMe: India's leading consumer health and wellness platform combining AI coaching, dietitian support, and biomarker tracking; comparable in Indian D2C health/wellness positioning and AI-driven personalisation.

Emerging players

• TruDiagnostic: Epigenetic age testing provider using multiple methylation clocks including DunedinPACE; directly comparable in TruAge/DunedinPACE epigenetic clock technology underpinning YouLabs Labs' research division.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YouLabs